33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-39.73
Negative P/E while PATH shows 141.48. Joel Greenblatt would examine path to profitability versus competitor.
75.72
Similar P/S to PATH's 71.48. David Dodd would investigate if similar multiples reflect similar business quality.
-10.79
Both companies show negative equity. Martin Whitman would check for industry-wide restructuring opportunities.
-158.53
Negative FCF while PATH shows P/FCF of 930.16. Joel Greenblatt would examine cash flow improvement potential.
-171.51
Negative operating cash flow while PATH shows P/OCF of 817.39. Joel Greenblatt would examine operational improvement potential.
-10.79
Both companies show negative fair values. Martin Whitman would check for industry-wide valuation issues.
-0.63%
Negative earnings while PATH shows yield of 0.18%. Joel Greenblatt would examine path to profitability.
-0.63%
Negative FCF while PATH shows yield of 0.11%. Joel Greenblatt would examine cash flow improvement potential.